2nd Taiwan COVID vaccine maker to apply for EUA on Phase 2 data

06/27/2021 08:58 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, June 27 (CNA) Taiwanese vaccine maker United Biomedical Inc. (UBI) Asia announced Sunday that it will seek emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate before the end of June after unveiling the interim results of its Phase 2 clinical trials.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.